Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Mach7 Technologies ( (AU:M7T) ) is now available.
Mach7 Technologies Limited has announced an update regarding its ongoing on-market buy-back program. As of May 26, 2025, the company has repurchased a total of 4,600,000 ordinary fully paid securities, including 50,000 bought back on the previous day. This buy-back initiative is part of the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology sector, focusing on providing innovative healthcare solutions. The company specializes in developing and offering software for medical imaging and data management, catering primarily to healthcare providers and institutions.
YTD Price Performance: -5.00%
Average Trading Volume: 256,941
Technical Sentiment Signal: Sell
Current Market Cap: A$91.67M
For an in-depth examination of M7T stock, go to TipRanks’ Stock Analysis page.